معرفی
Professor Dimitrios Lamprou is Chair of Biofabrication and Advanced Manufacturing at Queen's University Belfast's School of Pharmacy (ranked top 20 globally). He directs the MSc Industrial Pharmaceutics program and internationalization initiatives, while chairing the UK-Ireland Controlled Release Society. His research integrates nanotechnology, microfluidics, and 3D printing to develop advanced drug delivery systems, earning recognition as a global top 0.01% scholar in printing technologies and top 0.07% in microfluidics.
Research Focus: Lamprou leads interdisciplinary work in four pillars: (1) Nanoparticles for imaging/therapeutics, (2) Lab-on-a-chip diagnostics, (3) Implantable drug delivery systems, and (4) Sustainable pharmaceutical manufacturing. His lab pioneers 3D-printed medical devices, electrospun nanofibers, and microfluidic platforms for precision medicine.
Publication Trends: Recent works (2025) demonstrate strong emphasis on additive manufacturing for personalized therapeutics (e.g., nutrient-enriched 3D-printed formulations, biopolymeric hernia scaffolds) and advanced transdermal delivery systems. Over 50% of outputs involve translational applications of emerging technologies in clinical settings.
Awards & Honors:
- Royal Pharmaceutical Society Science Award
- SULSA Leaders Scheme Award
- Doctor Honoris Causa (Semmelweis University)
Advising & Grants: Supervised 30+ PhD students and 100+ UG/PG projects. Secured >£5M funding as PI/Co-I from EPSRC, NIH, Horizon 2020, and industry partners (Janssen, Merck). Current projects include microfluidic nanomedicine encapsulation (£19,170 CAPES internship) and amorphous solid dispersions for additive manufacturing.
Labs & Teams: Leads the Lamprou Research Lab specializing in nano-microfabrication. Key member of Advanced Manufacturing Innovation Centre (AMIC) and Materials & Advanced Technologies for Healthcare (MATCH) initiative. The lab holds a Gold Award in sustainability from the Laboratory Efficiency Assessment Framework.
